ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MYL Mylan NV

15.855
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Mylan NV NASDAQ:MYL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.855 15.71 15.90 0 01:00:00

Mylan to Report Third Quarter 2017 Financial Results on Nov. 6, 2017

17/10/2017 1:00pm

PR Newswire (US)


Mylan NV (NASDAQ:MYL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Mylan NV Charts.

HERTFORDSHIRE, England and PITTSBURGH, Oct. 17, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it will host a conference call and live webcast, on Monday, Nov. 6, 2017, at 10:30 a.m. ET, to review the company's financial results for the third quarter ended Sept. 30, 2017. Mylan will release its financial results on Nov. 6, before the open of the U.S. financial markets.

Mylan (PRNewsfoto/Mylan N.V.)

The briefing can be accessed live by calling 800.514.4861 or 678.809.2405 for international callers (ID#: 99489678) or at the following address on the company's website: investor.mylan.com.  A replay of the webcast also will be available on the website. 

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com.  We routinely post information that may be important to investors on our website at investor.mylan.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/mylan-to-report-third-quarter-2017-financial-results-on-nov-6-2017-300537764.html

SOURCE Mylan N.V.

Copyright 2017 PR Newswire

1 Year Mylan NV Chart

1 Year Mylan NV Chart

1 Month Mylan NV Chart

1 Month Mylan NV Chart

Your Recent History

Delayed Upgrade Clock